BNP Paribas Aktienanleihe FRE 27..../ DE000PG2Z9B7 /
1/9/2025 9:30:17 PM | Chg.-0.010 | Bid1/9/2025 | Ask1/9/2025 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.710EUR | -0.01% | 100.710 Bid Size: 20,000 |
100.810 Ask Size: 20,000 |
FRESENIUS SE+CO.KGAA... | 26.00 EUR | 3/27/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil